Martin Kevin J

Director · GLW

As of 2026-09-27, Martin Kevin J has 11 Form 4 transactions on record across 1 company — 5 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $3.2MIndirect: $0$3.2Mas of 2026-09-27
  • Direct $3.2M
  • Indirect $0
GLWdirect20,234 sh$3.2M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

GLW · 11 trades
2026-06-30: Award / grant, 137 sh ($35K)2026-03-31: Award / grant, 257 sh ($35K)2026-02-11: Award / grant, 1,806 sh ($0)2025-12-31: Award / grant, 385 sh ($34K)2025-09-30: Award / grant, 411 sh ($34K)2025-06-30: Award / grant, 642 sh ($34K)2025-03-31: Award / grant, 737 sh ($34K)2025-02-12: Award / grant, 4,519 sh ($0)2024-12-31: Award / grant, 708 sh ($34K)2024-06-28: Award / grant, 837 sh ($33K)2024-03-28: Award / grant, 986 sh ($32K)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
11 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-06-30GLWAward / grant13720,234Form 4
2026-03-31GLWAward / grant25720,097Form 4
2026-02-11GLWAward / grant1,80652,853Form 4
2025-12-31GLWAward / grant38519,840Form 4
2025-09-30GLWAward / grant41119,455Form 4
2025-06-30GLWAward / grant64219,044Form 4
2025-03-31GLWAward / grant73718,402Form 4
2025-02-12GLWAward / grant4,51951,047Form 4
2024-12-31GLWAward / grant70817,665Form 4
2024-06-28GLWAward / grant83716,237Form 4
2024-03-28GLWAward / grant98615,400Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.